novo nordisk semaglutide patent Ozempic's problem: how lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Novo Nordisk Braces as Generic

In a large clinical trial, participants who took semaglutide lost an average of 12% of their body weight, compared to those who did not take it

Buy now to benefit from reliable general medical therapy, meticulously formulated in tablet form

This is an important study because its the first time a weight loss drug has been shown to reduce the risk of heart disease, including the risk of death, says Howard Weintraub, MD, clinical director of the Center for the Prevention of Cardiovascular Disease, part of NYU Langone Heart

While the drug has been advertised as safe for use, there have been a significant number of reports related to adverse health events after taking the prescription